Bio-Techne TECH Cash Flow Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | $131.67M-16.7% | ||
| $100.33M-3.3% | $103.73M-2.2% | $106.11M-3.5% | $109.9M-0.9% | $110.85M+0.2% | ||
| $40.69M-2.2% | $41.58M-1.8% | $42.33M+3.7% | $40.83M-5.8% | $43.35M+8.1% | ||
| $294.86M+18.3% | $249.32M-0.8% | $251.25M-12.6% | $287.56M+8.6% | $264.85M-13.1% | ||
| $25.26M-3.9% | $26.3M-3.3% | $27.2M-12.3% | $31.01M-29.7% | $44.1M-12.5% | ||
| -$11.13M+21.5% | -$14.19M-6.7% | -$13.3M+62.6% | -$35.59M+19.8% | -$44.4M+14.6% | ||
| $49.82M-0.1% | $49.88M-0.5% | $50.15M-0.5% | $50.39M-0.5% | $50.63M0.0% | ||
| —— | —— | —— | —— | —— | ||
| $196M+36.1% | $144M+38.5% | $104M+35.1% | $77M-20.6% | $97M-34.0% | ||
| -$226.36M+10.1% | -$251.69M+12.2% | -$286.54M-12.9% | -$253.91M-13.6% | -$223.55M-7.5% | ||
| $69.15M+1,581% | -$4.67M— | —— | —— | —— | ||
| $269.6M+20.9% | $223.02M-0.5% | $224.06M-12.7% | $256.55M+16.2% | $220.76M-13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Techne generate?
- Bio-Techne (TECH) generated $294.9M in operating cash flow over the trailing twelve months.
- What is Bio-Techne's free cash flow?
- After $25.3M of capital expenditures, Bio-Techne's free cash flow was $269.6M over the trailing twelve months, up 22.1% year over year.
- Where does Bio-Techne's cash flow data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
